Detailed price information for Passage Bio Inc (PASG-Q) from The Globe and Mail including charting and trades.

EDT Passage Bio (PASG) trading halted, news pendingElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced that its Board of Directors has approved a 1-for-20 reverse ...

Passage Bio’s common stock will begin trading on a post-reverse stock split basis on July 14, 2025, under the Company’s existing trading symbol “PASG” with a new CUSIP number of 702712 209. The ...

Passage Bio, Inc. (“Passage Bio” or the “Company”) (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today ...

PHILADELPHIA - Passage Bio, Inc. (NASDAQ:PASG) announced Thursday that its Board of Directors has approved a 1-for-20 reverse stock split effective July 14, 2025, in an effort to regain compliance ...

Passage Bio’s common stock will begin trading on a post-reverse stock split basis on July 14, 2025, under the Company’s existing trading symbol “PASG” with a new CUSIP number of 702712 209.

Located a short hop from Aberystwyth, Pontarfynach, meaning 'the bridge on the Mynach', is a tiny village that can be reached via a heritage train that winds through woodland and countryside. It lies ...

Why Karoline Leavitt is so annoying From trolling the media to gaslighting the public, it's clear why Trump hired her as press secretary ...

In a murine FTD model, PBFT02 administration improved lysosomal function and reduced neuroinflammation. Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission to improve ...

PHILADELPHIA, June 23, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, ...